Active loading liposomal Irinotecan hydrochloride (cas 100286-90-6): Preparation, in vitro and in vivo evaluation
-
Add time:07/19/2019 Source:sciencedirect.com
The aim of the present study was to investigate the effect of various transmembrane ammonium salt gradients and different lipid composition on the loading efficiency of liposomal formulations of irinotecan hydrochloride (CPT-11), their behavior in vivo and cytotoxicity. Among ammonium salts studied, ammonium sulfate was successfully used to load CPT-11 into liposomes with the highest encapsulation efficiency. Subsequently, liposomal CPT-11 with different lipid composition was prepared by ammonium sulfate gradient method. CPT-11 can be loaded to a level over 90% into liposomes composed of soybean phospholipids/cholesterol (SPC-L) or hydrogenated natural soybean phospholipids/cholesterol (HSPC-L). In vitro release profiles were also investigated, indicating that HSPC-L had a lower release than that in SPC-L. In vivo, encapsulation of CPT-11 in both liposomal formulations showed higher area under the curve (AUC), a lower rate of clearance (CL) and smaller volume of distribution for CPT-11 than those of irinotecan hydrochloride solution (CPT-11-S). However, CL and AUC of 7-ethyl-10-hydroxycamptothecin (SN-38) were moderately improved in HSPC-L group. Based on the results of comparative pharmacokinetics of liposomal CPT-11 with different lipid composition, the in vitro cytotoxicity of HSPC-L was evaluated with human tumor cell. The result indicated that liposomal CPT-11 showed a great enhancement in vitro cytotoxicity. The results suggested that entrapment of CPT-11 in liposomes especially in those with high phase-transition temperature lipid by ammonium sulfate gradient would be a promising formulation with a better in vivo behavior.
We also recommend Trading Suppliers and Manufacturers of Irinotecan hydrochloride (cas 100286-90-6). Pls Click Website Link as below: cas 100286-90-6 suppliers
Prev:Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride (cas 100286-90-6) in rat plasma by using high performance liquid chromatography-diode array detector
Next:Impact of diet on irinotecan toxicity in mice) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Role of Glucocorticoid Receptor in the Regulation of Cellular Sensitivity to Irinotecan hydrochloride (cas 100286-90-6)07/26/2019
- Salvage chemotherapy with a combination of Irinotecan hydrochloride (cas 100286-90-6) and mitomycin C in elderly Japanese patients with gynecological malignancies: a pilot study07/25/2019
- Halloysite nanotubes as carriers for irinotecan: Synthesis and characterization by experimental and molecular simulation methods07/24/2019
- Voltammetric behaviour of the anticancer drug irinotecan and its metabolites in acetonitrile. Implications for electrochemical therapeutic drug monitoring07/23/2019
- Clinical effects of Irinotecan hydrochloride (cas 100286-90-6) in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer07/22/2019
- Effects of Δ9-tetrahydrocannabinol on irinotecan-induced clinical effects in rats07/20/2019
- Impact of diet on irinotecan toxicity in mice07/21/2019
- Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride (cas 100286-90-6) in rat plasma by using high performance liquid chromatography-diode array detector07/18/2019
- A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of Irinotecan hydrochloride (cas 100286-90-6) liposome injection07/17/2019
-
Health and Chemical more >


